hepatitis C

Gilead Sciences: Sovaldi Sales Slip But Less Than Feared
Barron's
Fri, 09/12/14 - 06:58 pm
Gilead Sciences
Sovaldi
hepatitis C
Can anything slow Gilead down? Analysts say no
CNBC
Mon, 09/8/14 - 08:16 pm
Gilead Sciences
Sovaldi
hepatitis C
Cheaper Version Of Gilead's Sovaldi Might Be On The Cards
Bidness Etc.
Fri, 09/5/14 - 08:05 am
Gilead Sciences
Sovaldi
hepatitis C
Gilead Close to Sending $84,000 Drug to Poor Countries
Bloomberg
Thu, 09/4/14 - 06:30 pm
Gilead Sciences
Sovaldi
hepatitis C
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Fri, 08/29/14 - 08:10 am
Gilead Sciences
Sovaldi
hepatitis C
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi
Yahoo/Zacks.com
Thu, 08/21/14 - 09:43 am
Gilead Sciences
Sovaldi
hepatitis C
UK Says Sovaldi Is Worth It. We Should Listen.
Forbes
Mon, 08/18/14 - 09:20 am
UK
Sovaldi
hepatitis C
Gilead Sciences
Gilead says wins favorable ruling on hep C drug
Yahoo/Reuters
Fri, 08/15/14 - 11:42 am
hepatitis C
Gilead Sciences
Roche
Sovaldi
Biotech Stock Achillion Is Soaring After Good News About Its Hepatitis C Drug
Yahoo/Business Insider
Fri, 08/15/14 - 11:30 am
ACH-3102
Achillion
hepatitis C
UK Recommends Covering Sovaldi Hepatitis C Pill
WSJ Pharmalot
Fri, 08/15/14 - 05:19 am
UK
Sovaldi
hepatitis C
Gilead Sciences
Most Popular News Headlines For Tuesday, August 12 2014
CP Wire
Wed, 08/13/14 - 08:54 am
Pfizer
M&A
Boehringer Ingelheim
drug reps
Vertex Pharmaceuticals
Incivek
hepatitis C
Most popular news headlines for Tuesday, August 12 2014
Wed, 08/13/14 - 08:53 am
Pfizer
M&A
Boehringer Ingelheim
drug reps
Vertex Pharmaceuticals
Incivek
hepatitis C
From Riches to Rags: Vertex Discontinues Incivek as Sales Evaporate
WSJ Online
Tue, 08/12/14 - 11:17 am
Vertex Pharmaceuticals
hepatitis C
Incivek
Even At $900 (Vs. $84,000 In US) Hep C Cure Sovaldi's Cost Could Be Unacceptable In India
Forbes
Fri, 08/8/14 - 08:36 am
India
Sovaldi
drug pricing
hepatitis C
Despite outcry over cost, breakthrough drug becomes treatment of choice for hepatitis C
Yahoo/AP
Tue, 07/29/14 - 09:35 am
hepatitis C
Sovaldi
Gilead Sciences
Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure
Forbes
Sat, 07/26/14 - 09:56 am
Sovaldi
Gilead Sciences
hepatitis
hepatitis C
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Motley Fool
Tue, 07/22/14 - 11:49 am
JNJ
hepatitis C
Olysio
JAMA: Hep C drugs could add $300 to every American's insurance premium
Fierce Pharma
Tue, 07/22/14 - 09:51 am
insurance
hepatitis C
Sovaldi
Gilead Sciences: Sovaldi’s a Blockbuster, the Question is How Big
Barron's
Mon, 07/21/14 - 11:01 am
Gilead Sciences
Sovaldi
hepatitis C

Pages